AstraZeneca (AZN) Stock Price Today—Real Time Charts and Quotes

Q: What are the 52-week high and low prices for AstraZeneca (AZN)?

AZN has a 52-week high of $212.72 and a 52-week low of $68.61, with the current price at $183.79.

Q: What is the price-to-earnings (P/E) ratio of AstraZeneca (AZN)? What does it indicate?

The current P/E ratio (TTM) of AZN is 26.526084836665042, indicating how much investors pay for each dollar of earnings. A higher P/E ratio often reflects stronger growth expectations, while a lower P/E ratio may suggest a more attractive valuation or slower growth. Comparing it with the average P/E of the Drug Manufacturers - General industry for a better context.

Q: What is the market cap of AstraZeneca (AZN)?

AstraZeneca (AZN) currently has a market cap of approximately $286.39B.

Q: What is the most recent quarterly earnings per share (EPS) for AstraZeneca (AZN)?

AstraZeneca (AZN)'s diluted earnings per share (Diluted EPS) is 6.749178825048419. EPS = Net Income / Total Diluted Shares, which is a key metric for measuring a company's profitability.

Q: Should you buy or sell AstraZeneca (AZN) now?

As of now, AZN is trading at $183.79, with a P/E ratio of 26.526084836665042 and a diluted EPS of 6.749178825048419. Your buy or sell decisions should be based on your investment goals and risk tolerance. We recommend making an overall judgment by considering AstraZeneca's financial reports, the outlook of the Drug Manufacturers - General sector, and your own holdings. Investing involves risk—please make decisions prudently.

Q: What factors can affect the stock price of AstraZeneca (AZN)?

Key factors include: company quarterly reports (revenue, EPS), competition and trends in the Drug Manufacturers - General sector, macroeconomic environment (interest rate, inflation), market sentiment, as well as major events like product releases and mergers & acquisitions.

Q: How to buy AstraZeneca (AZN) stock?

You can buy AstraZeneca (AZN) through Gate. Sign up for a Gate account and complete identity verification, then go to the AstraZeneca trading page to make a purchase. Gate supports fractional share trading, so you can start investing without buying a whole share.

$183.79

-$0.95(-0.51%)

*Data last updated: 2026-05-04 16:01 (UTC+8)

As of 2026-05-04 16:01, AstraZeneca (AZN) is priced at $183.79, with a total market cap of $286.39B, a P/E ratio of 26.52, and a dividend yield of 1.74%. Today, the stock price fluctuated between $183.65 and $185.10. The current price is 0.07% above the day's low and 0.70% below the day's high, with a trading volume of 1.69M. Over the past 52 weeks, AZN has traded between $68.61 to $212.72, and the current price is -13.60% away from the 52-week high.

AZN Key Stats

Yesterday's Close$187.37

Market Cap$286.39B

Volume1.69M

P/E Ratio26.52

Dividend Yield (TTM)1.74%

Dividend Amount$2.17

Diluted EPS (TTM)6.74

Net Income (FY)$10.25B

Revenue (FY)$58.73B

Earnings Date2026-07-27

EPS Estimate2.49

Revenue Estimate$15.41B

Shares Outstanding1.52B

Beta (1Y)0.275

Ex-Dividend Date2026-02-20

Dividend Payment Date2026-03-23

About AZN

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology. Its marketed products also comprise Vaxzevria, Beyfortus, Synagis, FluMist, Soliris, Ultomiris, Strensiq, Koselugo, and Kanuma for covid-19 and rare disease. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006; BenevolentAI for drug discovery for systemic lupus erythematosus; Lunit for developing AI-Powered Digital Pathology Risk Assessment Tools for NSCLC; and Absci Corporation for AI-driven drug discovery against an oncology target. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.

SectorHealthcare

IndustryDrug Manufacturers - General

CEOPascal Claude Roland Soriot

HeadquartersCambridge,None,GB

Official Websitehttps://www.astrazeneca.com

Employees (FY)2.02K

Average Revenue (1Y)$29.03M

Net Income per Employee$5.06M

Learn More about AstraZeneca (AZN)

Gate Learn Articles

All About Camino Network（CAM）

Camino Network (CAM) is a decentralized blockchain network tailored for the tourism industry. With its strong Web3 infrastructure, it is driving the development and innovation of the tourism industry. This article will comprehensively analyze Camino Network's technical architecture, token economics, consensus protocol, subnet mechanism, and future roadmap.

2025-02-05

Forkast (CGX): A Prediction Market Platform Built for Gaming and Internet Culture

Forkast (CGX) is an emerging prediction market platform designed for gamers and internet culture enthusiasts. It allows users to participate in prediction markets based on popular topics such as games, memes, streamers, breaking news, and more, providing an innovative way for investment and interaction. Incubated by Community Gaming, Forkast is attracting a growing number of Web3 users and cryptocurrency investors with advanced event management software and strong investment support. This article will delve into the features, advantages, and future development potential of Forkast (CGX).

2025-02-18

Kekius Maximus: Analysis of the Meme Craze and Related Tokens Triggered by Musk's New Avatar

Elon Musk changed his Twitter profile picture to Kekius Maximus, sparking a craze in the meme market. The name Kekius Maximus is derived from Pepe the Frog culture, associated with ancient Egyptian mythology and internet slang "Kek." This article will delve into the cultural background of Kekius Maximus and discuss meme tokens related to it, such as $KM and $KEKIUS, and how they have gained popularity on the Solana and ETH chains, while also cautioning investors to be aware of the risks associated with meme tokens.

2025-02-17

AstraZeneca (AZN) FAQ

What's the stock price of AstraZeneca (AZN) today?

AstraZeneca (AZN) is currently trading at $183.79, with a 24h change of -0.51%. The 52-week trading range is $68.61–$212.72.

What are the 52-week high and low prices for AstraZeneca (AZN)?

What is the price-to-earnings (P/E) ratio of AstraZeneca (AZN)? What does it indicate?

What is the market cap of AstraZeneca (AZN)?

What is the most recent quarterly earnings per share (EPS) for AstraZeneca (AZN)?

Should you buy or sell AstraZeneca (AZN) now?

What factors can affect the stock price of AstraZeneca (AZN)?

How to buy AstraZeneca (AZN) stock?

Risk Warning

The stock market involves a high level of risk and price volatility. The value of your investment may increase or decrease, and you may not recover the full amount invested. Past performance is not a reliable indicator of future results. Before making any investment decisions, you should carefully assess your investment experience, financial situation, investment objectives, and risk tolerance, and conduct your own research. Where appropriate, consult an independent financial adviser.

Disclaimer

The content on this page is provided for informational purposes only and does not constitute investment advice, financial advice, or trading recommendations. Gate shall not be held liable for any loss or damage resulting from such financial decisions. Further, take note that Gate may not be able to provide full service in certain markets and jurisdictions, including but not limited to the United States of America, Canada, Iran, and Cuba. For more information on Restricted Locations, please refer to the User Agreement.